Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie recently completed a Phase 1 clinical study titled ‘A Phase 1, ...

Researchers have found that patients with interstitial lung disease (ILD) are at greatly heightened risk of developing all ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Sept. 16, 2025 /PRNewswire/ -- USA News Group News Commentary – The FDA's accelerated approval of two oncology treatments in August 2025[1] ...

Chemotherapy plus anti-PD-1 or anti-PD-L1 in advanced PD-L1–negative squamous cell lung carcinoma: A systematic review and meta-analysis. First-line camrelizumab plus chemotherapy in patients with ...

Targeted Next-Generation Sequencing of Cell-Free DNA to Detect MYC-Immunoglobulin Translocation and Epstein-Barr Virus DNA in Plasma of Burkitt Lymphoma Patients in East Africa These findings ...

Individuals with interstitial lung disease (ILD) had more than a 13-fold higher incidence rate of lung cancer than those without ILD. The association persisted after adjustment for confounders, was ...

The EMA’s CHMP has adopted two positive opinions for Merck’s pembrolizumab (KEYTRUDA), potentially expanding its use in ...